Your browser doesn't support javascript.
Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network.
D'Ambrosio, Lia; Centis, Rosella; Dobler, Claudia C; Tiberi, Simon; Matteelli, Alberto; Denholm, Justin; Zenner, Dominik; Al-Abri, Seif; Alyaquobi, Fatma; Arbex, Marcos Abdo; Belilovskiy, Evgeny; Blanc, François-Xavier; Borisov, Sergey; Carvalho, Anna Cristina C; Chakaya, Jeremiah Muhwa; Cocco, Nicola; Codecasa, Luigi Ruffo; Dalcolmo, Margareth Pretti; Dheda, Keertan; Dinh-Xuan, Anh Tuan; Esposito, Susanna R; García-García, José-María; Li, Yang; Manga, Selene; Marchese, Valentina; Muñoz Torrico, Marcela; Pontali, Emanuele; Rendon, Adrián; Rossato Silva, Denise; Singla, Rupak; Solovic, Ivan; Sotgiu, Giovanni; van den Boom, Martin; Nhung, Nguyen Viet; Zellweger, Jean-Pierre; Migliori, Giovanni Battista.
  • D'Ambrosio L; Public Health Consulting Group, 6900 Lugano, Switzerland.
  • Centis R; Servizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy.
  • Dobler CC; The George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia.
  • Tiberi S; Department of Respiratory and Sleep Medicine, Liverpool Hospital, Sydney, NSW 2107, Australia.
  • Matteelli A; Department of Infection, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
  • Denholm J; Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
  • Zenner D; Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.
  • Al-Abri S; WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, 25123 Brescia, Italy.
  • Alyaquobi F; Victorian Tuberculosis Program, Melbourne Health, Melbourne, VIC 3000, Australia.
  • Arbex MA; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia.
  • Belilovskiy E; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC 3050, Australia.
  • Blanc FX; Centre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London E1 2AB, UK.
  • Borisov S; Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.
  • Carvalho ACC; Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.
  • Chakaya JM; Nestor Goulart Reis Hospital, Health Secretary São Paulo State, Sao Paulo 14801-320, Brazil.
  • Cocco N; Faculdade de Medicina, Universidade de Araraquara, Sao Paulo 14801-320, Brazil.
  • Codecasa LR; Moscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.
  • Dalcolmo MP; Service de Pneumologie, Centre Hospitalier Universitaire, L'institut du Thorax, F-44093 Nantes, France.
  • Dheda K; Moscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.
  • Dinh-Xuan AT; Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil.
  • Esposito SR; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi P.O. Box 43844-00100, Kenya.
  • García-García JM; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.
  • Li Y; ASST Santi Paolo e Carlo-Medicina Penitenziaria, 21100 Milan, Italy.
  • Manga S; TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, 20159 Milan, Italy.
  • Marchese V; Reference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro 21040-360, Brazil.
  • Muñoz Torrico M; South African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town 7701, South Africa.
  • Pontali E; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town 7701, South Africa.
  • Rendon A; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London 400706, UK.
  • Rossato Silva D; Respiratory Physiology Unit, Department of Respiratory Medicine, Cochin Hospital, Université de Paris, 75014 Paris, France.
  • Singla R; Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, 43126 Parma, Italy.
  • Solovic I; Tuberculosis Research Programme SEPAR, E-08029 Barcelona, Spain.
  • Sotgiu G; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • van den Boom M; Ministry of Health, Direccion General de Gestion de Riesgos en y Desastres en Salud, Lima 15072, Peru.
  • Nhung NV; Division of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.
  • Zellweger JP; WHO Collaborating Centre for TB/HIV Collaborative Activities and for TB Elimination Strategy, University of Brescia, 25123 Brescia, Italy.
  • Migliori GB; Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Antibiotics (Basel) ; 10(11)2021 Nov 05.
Article in English | MEDLINE | ID: covidwho-1518590
ABSTRACT
Tuberculosis (TB) does not respect borders, and migration confounds global TB control and elimination. Systematic screening of immigrants from TB high burden settings and-to a lesser degree TB infection (TBI)-is recommended in most countries with a low incidence of TB. The aim of the study was to evaluate the views of a diverse group of international health professionals on TB management among migrants. Participants expressed their level of agreement using a six-point Likert scale with different statements in an online survey available in English, French, Mandarin, Spanish, Portuguese and Russian. The survey consisted of eight sections, covering TB and TBI screening and treatment in migrants. A total of 1055 respondents from 80 countries and territories participated between November 2019 and April 2020. The largest professional groups were pulmonologists (16.8%), other clinicians (30.4%), and nurses (11.8%). Participants generally supported infection control and TB surveillance established practices (administrative interventions, personal protection, etc.), while they disagreed on how to diagnose and manage both TB and TBI, particularly on which TBI regimens to use and when patients should be hospitalised. The results of this first knowledge, attitude and practice study on TB screening and treatment in migrants will inform public health policy and educational resources.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials / Systematic review/Meta Analysis Language: English Year: 2021 Document Type: Article Affiliation country: Antibiotics10111355

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials / Systematic review/Meta Analysis Language: English Year: 2021 Document Type: Article Affiliation country: Antibiotics10111355